How a US Parent Defended Its Israeli Subsidiary's Transfer Pricing in an Audit

Result: A NIS 3.4M proposed transfer-pricing reassessment across three open years reduced to a voluntary adjustment of about NIS 600,000, with the arm's-length markup documented so future years were protected · Timeline: About 7 months from the audit notice to signed settlement · Challenge: The Tax Authority claimed the intercompany markup was too low and shifted profit out of Israel · Authority: Israel Tax Authority (Professional Division) · Financial Impact: Roughly NIS 2.8M in additional Israeli tax and penalties avoided, against a benchmarking study costing about NIS 55,000

Background

A US software group with a wholly-owned Israeli research and development subsidiary came to us in the middle of an audit that had unsettled its finance team in California. The Israeli company was structured the way many US technology groups structure their Israeli arm: it employed the engineers, it carried out the development work, and it was paid by the US parent on a cost-plus basis, meaning it recovered its costs plus a fixed markup and booked a small, steady profit in Israel. For years the markup had been set at 7 percent and nobody had questioned it. Then the Israel Tax Authority (Rashut HaMasim) opened a transfer-pricing audit covering three tax years, took the position that 7 percent was below the arm's-length range for what this subsidiary actually did, and proposed to reallocate profit to Israel, raising additional tax and penalties that came to roughly NIS 3.4 million across the open years.

The Challenge

Transfer pricing is the rule that intercompany dealings between related companies in different countries must be priced as if the two sides were strangers bargaining at arm's length. In Israel it lives in Section 85A of the Income Tax Ordinance 1961 and the regulations under it, the Income Tax Regulations on the Determination of Market Conditions 2006, in force since November 2006. The regulations do two things that mattered here. They require the Israeli price to fall within an arm's-length range built from comparable companies, and they put the burden on the taxpayer by requiring a transfer-pricing study, which must be produced to the Tax Authority within 60 days of a request. The parent had a US study prepared to American standards under Internal Revenue Code Section 482, but it had no current Israeli benchmarking study, and a US document built on US comparables does not automatically satisfy an Israeli examiner looking at Israeli and regional data.

The Tax Authority's argument had a real foundation, which is why it could not be waved away. The examiner said the Israeli subsidiary was not a plain-vanilla contract researcher earning a routine return. It carried some functions and some risk beyond pure development, and a company doing more than routine work should, on the Authority's view, earn more than a thin 7 percent. If that view stood, the profit taxed in Israel at the 23 percent corporate rate would jump, and the group faced a second problem stacked on the first: any profit the Authority pulled into Israel had already been taxed, in effect, in the United States, so without relief the same income would be taxed twice.

In Practice: Section 85A of the Income Tax Ordinance 1961 and the Determination of Market Conditions Regulations 2006 require intercompany prices to sit within an arm's-length range and oblige the taxpayer to hand over a transfer-pricing study within 60 days of an Israel Tax Authority request. On this group's Israeli cost base of about NIS 24 million a year, the gap between a 7 percent markup and the Authority's proposed reallocation drove a reassessment of roughly NIS 3.4 million in tax and penalties across three years, assessed at the 23 percent corporate rate.

What We Did

We did not argue the audit on principle. We answered it with data, because a transfer-pricing dispute is won or lost on comparables, not on assertion.

We commissioned a fresh benchmarking study built for Israel. That meant defining what the subsidiary actually did, function by function, and then searching Israeli and regional company databases for genuinely comparable service providers to establish the arm's-length range of markups for that profile. The study confirmed that a 7 percent markup was at the low end but not outside a defensible range for the subsidiary's real functions, and it identified where the group's own description of the entity had been looser than its actual conduct, which was part of what had drawn the examiner's eye. We reconciled that Israeli analysis with the parent's existing Section 482 study so the two told one consistent story rather than two conflicting ones, since an examiner who sees the group saying different things in different countries presses harder.

With the study in hand we met the Professional Division of the Tax Authority and negotiated. We accepted that the very bottom of the range was hard to defend and offered a modest upward adjustment of the markup for the open years, supported by the benchmarking, rather than fighting to hold 7 percent and risking the Authority's full reallocation. We also set the markup going forward at a rate the study supported, so the same dispute would not reopen every year. On the double-tax exposure, we mapped the route to relief under the United States and Israel tax treaty, whose mutual-agreement procedure lets the two tax administrations resolve a profit that both countries claim, so the group had a defined path to avoid being taxed twice on the reallocated amount.

Coordinating the two sides was its own task, and it fell squarely on the non-resident parent. The finance team in California was working nine or ten hours behind Tel Aviv, its advisers spoke the language of Section 482 and the Internal Revenue Service, and the Israeli examiner spoke the language of Section 85A and Israeli comparables. Left unmanaged, that gap produces exactly the inconsistency examiners punish: a functional analysis that reads one way in a US file and another way in an Israeli one. We ran the functional interviews once, with the engineers and the product leads describing what the Israeli team actually did, and used that single account to feed both the Israeli benchmarking and the reconciliation with the parent's US study. We also had the parent confirm in writing that it would make a correlative adjustment on the US return for the amount conceded in Israel, so the group was not quietly accepting a permanent double charge while it waited on the treaty route.

In Practice: Where a transfer-pricing adjustment pulls profit into Israel that a US group has already recognised at home, the mutual-agreement procedure under the United States and Israel tax treaty allows the two competent authorities to resolve the overlap and prevent double taxation. Raising the treaty route during the Israeli settlement, rather than after, kept the negotiated adjustment small enough that a full competent-authority proceeding was not needed, and the settlement was signed about 7 months after the audit notice.

The Outcome

The proposed NIS 3.4 million reassessment came down to a voluntary adjustment of about NIS 600,000 across the three open years, and the group avoided roughly NIS 2.8 million in additional tax and penalties. More valuable than the number was the documentation. The group left the audit with a current Israeli benchmarking study, a markup set at a defensible rate for future years, and a description of the subsidiary that matched what the company actually did. The next audit, if it comes, starts from a file that already answers the examiner's first question.

The benchmarking study cost about NIS 55,000, a figure the finance team had hesitated over before the audit and stopped questioning after it. The lesson the group took away is the one most US technology parents learn late: an American transfer-pricing study is necessary but not sufficient for the Israeli side, because the Israel Tax Authority tests the markup against Israeli comparables under its own regulations, and the 60-day clock to produce a study is not enough time to build one from scratch after the request arrives.

Key Takeaways

What this case illustrates for non-residents in similar situations:

1. A cost-plus markup on an Israeli subsidiary is only as safe as the study behind it. Under Section 85A and the 2006 regulations, the Israel Tax Authority tests the markup against Israeli comparables and can reallocate profit if it sits outside the arm's-length range.
2. A US Section 482 study does not by itself satisfy an Israeli examiner. Israel wants a benchmarking study built on Israeli and regional data, and the two studies must tell one consistent story about what the subsidiary does.
3. The 60-day deadline to produce a transfer-pricing study on request is not enough time to prepare one. Groups that wait until an audit lands are negotiating from weakness. The study belongs on the shelf before the examiner calls.
4. The description of the entity has to match its conduct. Much of the exposure here came from the subsidiary doing slightly more than the group's paperwork claimed, which invited the higher-return argument.
5. Double taxation is a separate problem from the Israeli adjustment. The mutual-agreement procedure under the United States and Israel tax treaty is the route to relief, and US groups weighing an Israeli research arm should understand how the subsidiary structure exposes them to Israeli transfer-pricing rules before the first audit rather than during it.

---

Facing a Similar Situation?

If your group runs an Israeli subsidiary on an intercompany markup and the Tax Authority has opened a transfer-pricing audit, or you want a benchmarking study in place before one does, the outcome usually turns on the quality of the comparables and how early the treaty relief is raised.

Contact us for a confidential consultation about your Israeli legal matter.